Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development NPK Q3 2023 Earnings Earnings per Share of 099 Highlights Modest Quarter SPRB Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares as Pipeline Progress Remains Key AKBA Q1 2026 Earnings EPS Misses Estimates Amid Operational Developments SAP Q1 2026 Earnings Modest EPS Beat Amidst Cloud Transition OPLN Q1 2026 Earnings EPS Beats Estimates by 124 Stock Rises